EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistanceFlorian Sevelda, Walter Berger|Journal of Experimental & Clinical Cancer Research|2015Cited by 75
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisDaniela Lötsch, Walter Berger|Oncotarget|2013Cited by 57
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibitionBernd Kubista, Walter Berger|Journal of Experimental & Clinical Cancer Research|2017Cited by 38
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose DeprivationDina Baier, Walter Berger|Pharmaceutics|2022Cited by 37
The Lipid Metabolism as Target and Modulator of BOLD‐100 Anticancer Activity: Crosstalk with Histone AcetylationDina Baier, Walter Berger|Advanced Science|2023Cited by 21